Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EIF3EP2, or eukaryotic translation initiation factor 3 subunit E pseudogene 2, is classified as a **pseudogene**, meaning it is a DNA sequence derived from the functional EIF3E gene but typically does not encode a functional protein. Unlike the canonical EIF3E gene—which encodes a component of the eukaryotic initiation factor 3 complex essential for protein synthesis and is involved in pathways regulating translation, cell proliferation, and has known disease associations—pseudogenes such as EIF3EP2 are generally considered **nonfunctional** and are not recognized as therapeutic targets or druggable entities[2]. There is no evidence supporting a distinct biological function, disease role, or clinical relevance for EIF3EP2 itself. **Key Notes:** - The entry relates to a **pseudogene**, not to the functional EIF3E gene or the eIF3 protein complex[2]. - Some pseudogenes can act as non-coding RNAs or have regulatory functions, but there is no direct evidence for such a role for EIF3EP2 in the available data[2]. - **EIF3E** (the functional gene) is involved in translation and cancer biology as part of the eIF3 complex, but these functions do **not apply** to EIF3EP2[1][3]. - EIF3EP2 does **not** have known clinical or therapeutic significance. If your intention was to refer to the functional, protein-coding gene EIF3E (eukaryotic translation initiation factor 3 subunit E), it is a distinct entity and would qualify for several of the information fields listed, but pseudogene 2 (EIF3EP2) does not.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 3 subunit E pseudogene 2 (EIF3EP2).